{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:47:08Z","timestamp":1772894828045,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Accurate prediction of drug response in cancer cells is a fundamental step toward achieving precision medicine and designing personalized therapies. In this study, a multi-branch deep learning framework is proposed that integrates multi-omics cellular data including gene expression, mutation, methylation, and biological pathways with structural features of drugs (molecular graphs and various chemical fingerprints) to enable drug response prediction. The graph structure of the drug is modeled using a three-layer Graph Convolutional Network (GCN), and chemical fingerprints are compressed using MLP networks. These multiple representations of drugs are integrated and then combined with cellular features in a Multi-head Bilinear Attention module to model the complex interactions between cells and drugs. In the final stage, an ensemble model based on XGBoost is used to refine the outputs. The MoGraphDRP model demonstrates significantly higher accuracy in drug response prediction compared to existing state-of-the-art methods. Experimental results show that the MoGraphDRP model outperforms advanced methods such as BANDRP, DeepCDR, and DeepTTA, achieving PCC\u2009=\u20090.9689, RMSE\u2009=\u20090.6622, and R\u00b2\u2009=\u20090.9388. This model not only accurately reconstructs missing IC50 values but also effectively distinguishes between sensitive and resistant drugs in unknown combinations. The MoGraphDRP framework can serve as a powerful, interpretable, and reliable tool for analyzing drug response and designing preclinical treatments.<\/jats:p>","DOI":"10.1371\/journal.pone.0341458","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:33:24Z","timestamp":1772822004000},"page":"e0341458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["MoGraphDRP: Multi-omics and graph fusion with bilinear attention for predicting drug sensitivity"],"prefix":"10.1371","volume":"21","author":[{"given":"Zahra","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-9023","authenticated-orcid":true,"given":"Jamshid","family":"Pirgazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-5857","authenticated-orcid":true,"given":"Ali Ghanbari","family":"Sorkhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"7619","key":"pone.0341458.ref001","doi-asserted-by":"crossref","DOI":"10.1038\/537S49a","article-title":"Precision medicine","volume":"537","author":"R Hodson","year":"2016","journal-title":"Nature"},{"issue":"7","key":"pone.0341458.ref002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jgg.2021.03.007","article-title":"Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine","volume":"48","author":"F Feng","year":"2021","journal-title":"J Genet Genom"},{"key":"pone.0341458.ref003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-020-0122-1","article-title":"Machine learning approaches to drug response prediction: challenges and recent progress","volume":"4","author":"G Adam","year":"2020","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"pone.0341458.ref004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"JS Lopez","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"pone.0341458.ref005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40169-018-0185-6","article-title":"Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs","volume":"7","author":"H Maeda","year":"2018","journal-title":"Clin Transl Med"},{"issue":"7391","key":"pone.0341458.ref006","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"key":"pone.0341458.ref007","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"pone.0341458.ref008","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"S Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"pone.0341458.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061318","article-title":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties","volume":"8","author":"MP Menden","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"pone.0341458.ref010","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/ci500152b","article-title":"Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization","volume":"54","author":"M Ammad-ud-din","year":"2014","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0341458.ref011","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12885-017-3500-5","article-title":"Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization","volume":"17","author":"L Wang","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0341458.ref012","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer Drug Response Profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Y Chang","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0341458.ref013","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.celrep.2019.11.017","article-title":"A deep learning framework for predicting response to therapy in cancer","volume":"29","author":"T Sakellaropoulos","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"pone.0341458.ref014","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41598-020-58821-x","article-title":"RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance","volume":"10","author":"J Choi","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0341458.ref015","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","article-title":"GraphDTA: predicting drug-target binding affinity with graph neural networks","volume":"37","author":"T Nguyen","year":"2021","journal-title":"Bioinformatics"},{"issue":"15","key":"pone.0341458.ref016","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.0601231103","article-title":"Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer","volume":"103","author":"L Ein-Dor","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0341458.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002375","article-title":"Ten years of pathway analysis: current approaches and outstanding challenges","volume":"8","author":"P Khatri","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"pone.0341458.ref018","first-page":"22118","article-title":"Open Graph Benchmark: Datasets for machine learning on graphs","volume":"33","author":"W Hu","year":"2020","journal-title":"Adv Neural Inf Process Syst"},{"key":"pone.0341458.ref019","article-title":"Semi-supervised classification with graph convolutional networks","volume-title":"International Conference on Learning Representations (ICLR)","author":"TN Kipf","year":"2017"},{"key":"pone.0341458.ref020","article-title":"Graph Attention Networks","volume-title":"International Conference on Learning Representations (ICLR)","author":"P Veli\u010dkovi\u0107","year":"2018"},{"key":"pone.0341458.ref021","article-title":"How powerful are graph neural networks?","volume-title":"International Conference on Learning Representations (ICLR)","author":"K Xu","year":"2019"},{"key":"pone.0341458.ref022","article-title":"DeepCDR: a hybrid graph convolutional network for predicting cancer drug response","volume":"36","author":"Q Liu","year":"2020","journal-title":"Bioinformatics"},{"issue":"3","key":"pone.0341458.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac100","article-title":"DeepTTA: a transformer-based model for predicting cancer drug response","volume":"23","author":"L Jiang","year":"2022","journal-title":"Brief Bioinform"},{"issue":"2","key":"pone.0341458.ref024","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1109\/TCBB.2022.3206888","article-title":"Graph transformer for drug response prediction","volume":"20","author":"T Chu","year":"2023","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"1","key":"pone.0341458.ref025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12859-023-05618-0","article-title":"GPDRP: a multimodal framework for drug response prediction with graph transformer","volume":"24","author":"Y Yang","year":"2023","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"pone.0341458.ref026","article-title":"BANDRP: a bilinear attention network for anti-cancer drug response prediction based on fingerprint and multi-omics","volume":"25","author":"C Cao","year":"2024","journal-title":"Brief Bioinform"},{"issue":"43","key":"pone.0341458.ref027","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0341458.ref028","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12859-019-2910-6","article-title":"Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network","volume":"20","author":"P Liu","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"pone.0341458.ref029","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","article-title":"Gene expression based inference of cancer drug sensitivity","volume":"13","author":"S Chawla","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0341458.ref030","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac501","article-title":"GADRP: graph convolutional networks and autoencoders for cancer drug response prediction","volume":"24","author":"H Wang","year":"2023","journal-title":"Brief Bioinform"},{"key":"pone.0341458.ref031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"pone.0341458.ref032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13321-020-00456-1","article-title":"An open source chemical structure curation pipeline using RDKit","volume":"12","author":"AP Bento","year":"2020","journal-title":"J Cheminform"},{"issue":"5","key":"pone.0341458.ref033","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"D Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"pone.0341458.ref034","article-title":"Explainable substructure partition fingerprint for protein, drug, and more.","volume-title":"NeurIPS Learning Meaningful Representation of Life Workshop","author":"K Huang","year":"2019"},{"issue":"12","key":"pone.0341458.ref035","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"3","key":"pone.0341458.ref036","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"F Iorio","year":"2016","journal-title":"Cell"},{"issue":"11","key":"pone.0341458.ref037","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Z Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"pone.0341458.ref038","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"V Gandhi","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"pone.0341458.ref039","unstructured":"DrugBank. Fludarabine. DrugBank Online. 2024. Available from: https:\/\/go.drugbank.com\/drugs\/DB00472"},{"issue":"11","key":"pone.0341458.ref040","first-page":"72","article-title":"Repurposing cimetidine in oncology: an updated review","volume":"19","author":"RF Sweis","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"pone.0341458.ref041","unstructured":"DrugBank. Cimetidine. DrugBank Online. 2024. Available from: https:\/\/go.drugbank.com\/drugs\/DB00352"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:33:33Z","timestamp":1772822013000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341458"}},"subtitle":[],"editor":[{"given":"O-Joun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}